Kantonsspital St.Gallen
login

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost–utility analysis

Markus Joerger, K Matter-Walstra & Martin Früh

citation Joerger M, Matter-Walstra K, Früh M. Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost–utility analysis. Ann Oncol 2012; 22:567-574.
   
type journal paper/review (Deutsch)
date of publishing 2012
journal title Ann Oncol (22)
pages 567-574